CN Patent
CN101255175A — 一种塞克硝唑水溶性盐及其制备方法
Assigned to Hefei University of Technology · Expires 2008-09-03 · 18y expired
What this patent protects
本发明涉及一种治疗阿米巴痢疾的药物塞克硝唑的水溶性衍生物,即塞克硝唑磷酸盐或琥珀酸单酯盐,具上述结构的化合物是塞克硝唑的化学衍生物,可在塞克硝唑的范围内发挥药效。衍生物的水溶性显著优于塞克硝唑,因此可被制成后者所不能制备的剂型,如注射用粉针剂。本发明还涉及到上述塞克硝唑磷酸盐和塞克硝唑琥珀酸单酯盐的制备方法。
USPTO Abstract
本发明涉及一种治疗阿米巴痢疾的药物塞克硝唑的水溶性衍生物,即塞克硝唑磷酸盐或琥珀酸单酯盐,具上述结构的化合物是塞克硝唑的化学衍生物,可在塞克硝唑的范围内发挥药效。衍生物的水溶性显著优于塞克硝唑,因此可被制成后者所不能制备的剂型,如注射用粉针剂。本发明还涉及到上述塞克硝唑磷酸盐和塞克硝唑琥珀酸单酯盐的制备方法。
Drugs covered by this patent
- Solosec (SECNIDAZOLE) · Evofem Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.